PTC Therapeutics, Inc. (PTCT)
USD 41.88
(-3.15%)
USD 41.88
(-3.15%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 872.33 Million USD | -0.68% |
| 2022 | 654.12 Million USD | 29.21% |
| 2021 | 506.26 Million USD | 39.92% |
| 2020 | 361.82 Million USD | 22.72% |
| 2019 | 294.84 Million USD | 16.97% |
| 2018 | 252.06 Million USD | 32.79% |
| 2017 | 189.81 Million USD | 643.45% |
| 2016 | -34.92 Million USD | 58.93% |
| 2015 | -85.05 Million USD | -49.54% |
| 2014 | -56.87 Million USD | -141.52% |
| 2013 | -23.54 Million USD | -169.37% |
| 2012 | 33.94 Million USD | -65.7% |
| 2011 | 98.96 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 168.31 Million USD | 17.01% |
| 2024 Q1 | 143.84 Million USD | -28.35% |
| 2023 FY | 649.7 Million USD | -0.68% |
| 2023 Q4 | 200.76 Million USD | 7.31% |
| 2023 Q1 | 206.23 Million USD | 31.77% |
| 2023 Q3 | 187.08 Million USD | -6.96% |
| 2023 Q2 | 201.07 Million USD | -2.5% |
| 2022 Q2 | 155.88 Million USD | 12.47% |
| 2022 Q3 | 203.11 Million USD | 30.3% |
| 2022 Q4 | 156.51 Million USD | -22.94% |
| 2022 FY | 654.12 Million USD | 29.21% |
| 2022 Q1 | 138.6 Million USD | -11.1% |
| 2021 FY | 506.26 Million USD | 39.92% |
| 2021 Q4 | 155.9 Million USD | 17.92% |
| 2021 Q3 | 132.2 Million USD | 20.94% |
| 2021 Q2 | 109.31 Million USD | 0.44% |
| 2021 Q1 | 108.83 Million USD | -4.51% |
| 2020 Q2 | 69.93 Million USD | 8.98% |
| 2020 FY | 361.82 Million USD | 22.72% |
| 2020 Q1 | 64.17 Million USD | -30.93% |
| 2020 Q3 | 113.73 Million USD | 62.63% |
| 2020 Q4 | 113.97 Million USD | 0.21% |
| 2019 Q2 | 82.31 Million USD | 60.74% |
| 2019 Q3 | 68.41 Million USD | -16.89% |
| 2019 FY | 294.84 Million USD | 16.97% |
| 2019 Q1 | 51.2 Million USD | -37.99% |
| 2019 Q4 | 92.91 Million USD | 35.82% |
| 2018 Q3 | 50.29 Million USD | -23.99% |
| 2018 Q4 | 82.57 Million USD | 64.17% |
| 2018 FY | 252.06 Million USD | 32.79% |
| 2018 Q2 | 66.17 Million USD | 24.81% |
| 2018 Q1 | 53.01 Million USD | -29.87% |
| 2017 Q4 | 75.59 Million USD | 87.72% |
| 2017 FY | 189.81 Million USD | 643.45% |
| 2017 Q1 | 26.5 Million USD | 132640.0% |
| 2017 Q2 | 47.2 Million USD | 78.07% |
| 2017 Q3 | 40.27 Million USD | -14.69% |
| 2016 Q1 | -12.5 Million USD | 43.96% |
| 2016 FY | -34.92 Million USD | 58.93% |
| 2016 Q3 | -8.41 Million USD | 36.26% |
| 2016 Q4 | -20 Thousand USD | 99.76% |
| 2016 Q2 | -13.19 Million USD | -5.52% |
| 2015 FY | -85.05 Million USD | -49.54% |
| 2015 Q4 | -22.31 Million USD | -6.94% |
| 2015 Q3 | -20.86 Million USD | 4.38% |
| 2015 Q2 | -21.82 Million USD | 3.15% |
| 2015 Q1 | -22.53 Million USD | -47.56% |
| 2014 Q1 | -6.74 Million USD | 39.2% |
| 2014 FY | -56.87 Million USD | -141.52% |
| 2014 Q3 | -17.96 Million USD | -6.35% |
| 2014 Q4 | -15.26 Million USD | 15.02% |
| 2014 Q2 | -16.89 Million USD | -150.59% |
| 2013 Q3 | 1.56 Million USD | 117.74% |
| 2013 Q4 | -11.08 Million USD | -806.61% |
| 2013 FY | -23.54 Million USD | -169.37% |
| 2013 Q1 | -5.18 Million USD | -178.08% |
| 2013 Q2 | -8.84 Million USD | -70.58% |
| 2012 Q1 | 12.52 Million USD | 0.0% |
| 2012 FY | 33.94 Million USD | -65.7% |
| 2012 Q3 | 7.19 Million USD | -5.14% |
| 2012 Q4 | 6.64 Million USD | -7.71% |
| 2012 Q2 | 7.58 Million USD | -39.44% |
| 2011 FY | 98.96 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| AbCellera Biologics Inc. | 38.02 Million USD | -2194.112% |
| Alkermes plc | 1.37 Billion USD | 36.543% |
| Agenus Inc. | 139.61 Million USD | -524.815% |
| Aptorum Group Limited | -1.11 Million USD | 78358.311% |
| Ardelyx, Inc. | 106.66 Million USD | -717.858% |
| Dyadic International, Inc. | 922.95 Thousand USD | -94415.346% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | -4041.95% |
| Lantern Pharma Inc. | -174.84 Thousand USD | 499025.322% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | 6630.513% |
| Novavax, Inc. | 639.93 Million USD | -36.316% |
| Janux Therapeutics, Inc. | -46.83 Million USD | 1962.414% |
| Pyxis Oncology, Inc. | -2 Million USD | 43716.8% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | 168913.305% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -4480.875% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | 1974246.827% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | 165628.653% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 988.172% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -108670.075% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 1063924.39% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | -544.89% |
| Clearside Biomedical, Inc. | 7.87 Million USD | -10982.912% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 999.779% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 42.53% |
| AlloVir, Inc. | -398 Thousand USD | 219279.899% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | -262.364% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -205639.623% |
| Bicycle Therapeutics plc | -129.52 Million USD | 773.515% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | -726846.667% |
| ChromaDex Corporation | 50.78 Million USD | -1617.873% |
| Chimerix, Inc. | 324 Thousand USD | -269139.506% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | 2898.85% |
| Caribou Biosciences, Inc. | -77.59 Million USD | 1224.173% |
| CRISPR Therapeutics AG | 240.95 Million USD | -262.031% |
| Precision BioSciences, Inc. | 40.47 Million USD | -2055.406% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 988.661% |
| Fortress Biotech, Inc. | 57.85 Million USD | -1407.849% |
| Fortress Biotech, Inc. | 57.85 Million USD | -1407.849% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | -5162.327% |
| ImmuCell Corporation | 4.39 Million USD | -19742.576% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 922.005% |
| Immix Biopharma, Inc. | -5468.00 USD | 15953574.762% |
| Incyte Corporation | 3.44 Billion USD | 74.646% |
| Innoviva, Inc. | 261.06 Million USD | -234.145% |
| IO Biotech, Inc. | -756 Thousand USD | 115488.36% |
| Jaguar Health, Inc. | 7.72 Million USD | -11193.837% |
| Keros Therapeutics, Inc. | -664 Thousand USD | 131475.904% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | -628.446% |
| ContextLogic Inc. | 59 Million USD | -1378.536% |
| MiMedx Group, Inc. | 266.84 Million USD | -226.91% |
| MEI Pharma, Inc. | 49.32 Million USD | -1668.476% |
| NextCure, Inc. | -3.68 Million USD | 23779.045% |
| Onconetix, Inc. | -1.12 Million USD | 77492.041% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | 3111.378% |
| Opthea Limited | 21.72 Thousand USD | -4016179.926% |
| Psyence Biomedical Ltd. | -240.00 USD | 363473433.333% |
| Vaxcyte, Inc. | -75 Million USD | 1263.115% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | 1521810.917% |
| Precigen, Inc. | 106 Thousand USD | -822858.491% |
| Pharming Group N.V. | 220.1 Million USD | -296.329% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | -169285.631% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | -86355.5% |
| PureTech Health plc | -1.6 Million USD | 54518.964% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | -694.68% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 580.87% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | 2024.624% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | 4067.508% |
| Acelyrin, Inc. | -115 Thousand USD | 758653.043% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | 8679196.607% |
| Summit Therapeutics Inc. | -2.05 Million USD | 42652.976% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | 152873.38% |
| Senti Biosciences, Inc. | -2.68 Million USD | 32613.455% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | -21433.843% |
| Elevation Oncology, Inc. | -39 Thousand USD | 2236858.974% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | 18281.242% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | 22229.005% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | -2894.734% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | -175774.194% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | 1586165.455% |
| Wave Life Sciences Ltd. | 104.09 Million USD | -737.987% |
| Seer, Inc. | 7.02 Million USD | -12314.06% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | -19825.445% |
| Aadi Bioscience, Inc. | 21.54 Million USD | -3948.902% |
| ESSA Pharma Inc. | -118.49 Thousand USD | 736304.437% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | 608843.833% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | -143140.722% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | -624.087% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | -178.105% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | 17446820.0% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | -33790.287% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | 1719327.434% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | -2868.442% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | 376106.897% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | 177404.065% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | 12389.884% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | 183925.77% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | 8387946.154% |
| Soligenix, Inc. | 97.31 Thousand USD | -896341.307% |
| Century Therapeutics, Inc. | -10.8 Million USD | 8170.46% |
| Kura Oncology, Inc. | -849 Thousand USD | 102848.645% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 1399.976% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | 593525.85% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | -780.8% |
| Autolus Therapeutics plc | -4.86 Million USD | 18023.485% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | -2007.805% |
| Eterna Therapeutics Inc. | -168 Thousand USD | 519347.619% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | -820.934% |
| GRI Bio, Inc. | 10.84 Million USD | -7946.638% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -34244.126% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | 10141.856% |
| IGM Biosciences, Inc. | -211.66 Million USD | 512.14% |
| INmune Bio, Inc. | 155 Thousand USD | -562697.419% |
| Heron Therapeutics, Inc. | 61.93 Million USD | -1308.379% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 58012.847% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 134625.502% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | 2980000.253% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | -216899.005% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | 43804.208% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | 278801.597% |
| Coherus BioSciences, Inc. | 94.46 Million USD | -823.488% |
| Verastem, Inc. | -62 Thousand USD | 1407093.548% |
| Abeona Therapeutics Inc. | 2.43 Million USD | -35724.887% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | 334328.352% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | -28718.5% |
| Histogen Inc. | 3.76 Million USD | -23045.025% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | -151300.173% |
| Surrozen, Inc. | -27.23 Million USD | 3303.584% |
| Organovo Holdings, Inc. | -5.38 Million USD | 16287.345% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | -1.2 Million USD | 72500.239% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | 3501.318% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | -4250.369% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | 44057473.737% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | -14279.742% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | 1299553.308% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | -463.557% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -598210.014% |
| Apollomics, Inc. | 127 Thousand USD | -686778.74% |
| Amarin Corporation plc | 165.54 Million USD | -426.961% |
| Mesoblast Limited | -9.81 Million USD | 8987.784% |
| Turnstone Biologics Corp. | 16.5 Million USD | -5184.963% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 889.523% |
| Synaptogenix, Inc. | -6347.00 USD | 13744168.064% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | 1710562.745% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | -440.598% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 1.75 Billion USD | 50.369% |
| Better Therapeutics, Inc. | -2.72 Million USD | 32065.409% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 877.753% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | -158.026% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 7646804.067% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | 14035.08% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 78830.686% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | -11820.414% |
| Insmed Incorporated | 239.63 Million USD | -264.027% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 3.57 Million USD | -24280.548% |
| OmniAb, Inc. | 14.66 Million USD | -5847.61% |
| Alector, Inc. | -95.05 Million USD | 1017.736% |
| Seres Therapeutics, Inc. | 125.62 Million USD | -594.419% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | 2107.077% |
| Zai Lab Limited | 170.9 Million USD | -410.428% |
| Revance Therapeutics, Inc. | 81.87 Million USD | -965.423% |
| Aura Biosciences, Inc. | -1.29 Million USD | 67461.853% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -670927.692% |
| Immunic, Inc. | -111 Thousand USD | 785988.288% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | -5402.309% |
| Veracyte, Inc. | 248.14 Million USD | -251.539% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 112.481% |
| FibroGen, Inc. | 128.9 Million USD | -576.733% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | 154669603.546% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | 7577.026% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 74.333% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | -224150.9% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | -145.49% |
| TG Therapeutics, Inc. | 219.1 Million USD | -298.131% |
| Galecto, Inc. | -830 Thousand USD | 105200.723% |
| Calithera Biosciences, Inc. | -1.38 Million USD | 63084.549% |
| Fortrea Holdings Inc. | 424 Million USD | -105.74% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 1112.378% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | 153951.146% |
| XBiotech Inc. | -1.74 Million USD | 50119.266% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 78830.686% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | 1977.162% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 1254.892% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | -1088.42% |
| Theravance Biopharma, Inc. | 16.8 Million USD | -5091.549% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | -124.228% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | 1857.077% |
| Vaxxinity, Inc. | -2.23 Million USD | 39148.165% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | -166.973% |
| Gain Therapeutics, Inc. | -11.32 Million USD | 7803.534% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | -3467.69% |
| NexImmune, Inc. | -1.02 Million USD | 85208.276% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | -16154270.37% |
| Marker Therapeutics, Inc. | -7.1 Million USD | 12376.643% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 92.281% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | 1305464.598% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | 24665.925% |
| Ainos, Inc. | -253.73 Thousand USD | 343900.767% |
| Pluri Inc. | 322 Thousand USD | -270811.801% |
| Prothena Corporation plc | -129.2 Million USD | 775.177% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | -1630.004% |
| Celularity Inc. | 6.75 Million USD | -12813.93% |
| Rallybio Corporation | -150 Thousand USD | 581657.333% |
| Cue Biopharma, Inc. | -32.6 Million USD | 2775.303% |
| MeiraGTx Holdings plc | 287 Thousand USD | -303849.826% |
| Omeros Corporation | -69.77 Million USD | 1350.141% |
| Humacyte, Inc. | -76.55 Million USD | 1239.564% |
| Immunocore Holdings plc | 248.39 Million USD | -251.195% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | 5850.781% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | -1298.378% |
| Blueprint Medicines Corporation | 236.58 Million USD | -268.721% |
| CalciMedica, Inc. | -58 Thousand USD | 1504127.586% |
| Cabaletta Bio, Inc. | -1.42 Million USD | 61273.633% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | -2902.361% |
| Scholar Rock Holding Corporation | -2.84 Million USD | 30772.855% |
| Sana Biotechnology, Inc. | -30.86 Million USD | 2926.295% |
| Pulmatrix, Inc. | -8.22 Million USD | 10712.36% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | 74658.632% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | 218730.576% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 318.744% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | -31328.906% |
| Cytokinetics, Incorporated | -322.59 Million USD | 370.414% |
| Eloxx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -101086.746% |
| Protara Therapeutics, Inc. | -341 Thousand USD | 255917.009% |
| Vor Biopharma Inc. | -3.49 Million USD | 25080.985% |
| Roivant Sciences Ltd. | 109.23 Million USD | -698.587% |
| Evogene Ltd. | 1.39 Million USD | -62254.253% |
| ProKidney Corp. | -3.16 Million USD | 27627.169% |
| Applied Therapeutics, Inc. | -43.91 Million USD | 2086.555% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | -12621.832% |
| CorMedix Inc. | -205.56 Thousand USD | 424466.371% |
| BioLineRx Ltd. | 1.1 Million USD | -78630.686% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 1208.841% |
| Galectin Therapeutics Inc. | -33 Thousand USD | 2643542.424% |
| Atai Life Sciences N.V. | -5000.00 USD | 17446820.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | 715956.851% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | 908783.333% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | 62903.168% |
| Sagimet Biosciences Inc. | 2 Million USD | -43516.8% |
| MediciNova, Inc. | 979.7 Thousand USD | -88940.681% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 1134.566% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 922669.933% |
| GeoVax Labs, Inc. | -20.72 Million USD | 4309.96% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | -256.733% |
| Biomea Fusion, Inc. | -4.2 Million USD | 20864.961% |
| Mereo BioPharma Group plc | 7.42 Million USD | -11647.051% |
| Cullinan Oncology, Inc. | -310 Thousand USD | 281498.71% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | 7269566.667% |
| Absci Corporation | -41.84 Million USD | 2184.485% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 17446820.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 1242.205% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | 35546.404% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | -308.139% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | 92803.082% |
| Allakos Inc. | -6.14 Million USD | 14305.113% |
| Imunon, Inc. | -720 Thousand USD | 121256.936% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 1364.328% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | -83.305% |
| BioAtla, Inc. | -103.73 Million USD | 940.96% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 7646804.067% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | 490176.404% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 459.254% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | 280593.891% |
| XOMA Corporation | 3.86 Million USD | -22493.525% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 1344.683% |
| Cara Therapeutics, Inc. | 14.79 Million USD | -5796.553% |
| aTyr Pharma, Inc. | -2.38 Million USD | 36629.983% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | -6901.091% |
| Akero Therapeutics, Inc. | -29 Thousand USD | 3008155.172% |
| Viridian Therapeutics, Inc. | -1 Million USD | 86641.27% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | -6710276823.077% |
| Akari Therapeutics, Plc | -4000.00 USD | 21808500.0% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | -36.968% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -447922.68% |
| UroGen Pharma Ltd. | 73.35 Million USD | -1089.246% |
| Sutro Biopharma, Inc. | -26.69 Million USD | 3367.91% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | -7513560.637% |
| Orgenesis Inc. | -5.72 Million USD | 15337.31% |
| Entera Bio Ltd. | -56 Thousand USD | 1557842.857% |
| GH Research PLC | -315 Thousand USD | 277032.063% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | 461653.439% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | 166259.238% |
| Xencor, Inc. | -85.26 Million USD | 1123.148% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | 394863.256% |
| Replimune Group, Inc. | -2.65 Million USD | 32956.347% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | 87225.912% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | -390.506% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -447922.68% |
| Portage Biotech Inc. | -54 Thousand USD | 1615537.037% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 922669.933% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | 231488.859% |
| OncoCyte Corporation | 413 Thousand USD | -211119.37% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | 19406907.564% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | 392944244.144% |
| Purple Biotech Ltd. | -196 Thousand USD | 445169.388% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | -9627.208% |
| scPharmaceuticals Inc. | 9.78 Million USD | -8817.767% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | 8451.743% |
| HilleVax, Inc. | -2.15 Million USD | 40560.853% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | 899415.464% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | -15 Thousand USD | 5814122.927% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | 130689.222% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | 3792865.217% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | -7506.16 USD | 11621701.458% |
| Savara Inc. | -44.26 Million USD | 2070.846% |
| Curis, Inc. | 9.81 Million USD | -8791.408% |
| Daré Bioscience, Inc. | 2.76 Million USD | -31397.71% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | 699154.396% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | 50553.21% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | 382703.509% |
| BeiGene, Ltd. | 2.07 Billion USD | 58.038% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | 31300.544% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 318.267% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | -1438.837% |
| Erasca, Inc. | -3.73 Million USD | 23474.491% |
| bluebird bio, Inc. | -4.03 Million USD | 21746.055% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 3091516.826% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 54.193% |
| DBV Technologies S.A. | 15.72 Million USD | -5446.389% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 3091516.826% |
| Moderna, Inc. | 2.15 Billion USD | 59.52% |
| Vincerx Pharma, Inc. | -915 Thousand USD | 95437.268% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -10796.028% |
| Molecular Templates, Inc. | 50.39 Million USD | -1630.997% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | 162849.254% |
| Travere Therapeutics, Inc. | 133.78 Million USD | -552.029% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | 14120.186% |
| Spruce Biosciences, Inc. | -39.34 Million USD | 2317.258% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 884.983% |
| Cogent Biosciences, Inc. | -3.58 Million USD | 24412.598% |
| MacroGenics, Inc. | 50.52 Million USD | -1626.475% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | -6.09 Million USD | 14405.28% |
| Prime Medicine, Inc. | -147.9 Million USD | 689.795% |
| Aditxt, Inc. | -111.66 Thousand USD | 781343.059% |
| Adagene Inc. | 18.11 Million USD | -4716.478% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | -178657.377% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | -522.199% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | -452.685% |
| SciSparc Ltd. | 2.19 Million USD | -39623.862% |
| Vericel Corporation | 135.57 Million USD | -543.43% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 3482618.264% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | 2815721.974% |
| Generation Bio Co. | -73.91 Million USD | 1280.252% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | 199719.222% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | -1497.129% |
| Invivyd, Inc. | -2.02 Million USD | 43114.596% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 389.966% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | 843441.905% |
| Spero Therapeutics, Inc. | 96.36 Million USD | -805.213% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | -787.531% |
| ADMA Biologics, Inc. | 88.21 Million USD | -888.841% |
| Clene Inc. | 533 Thousand USD | -163565.291% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | -3518.273% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | 91253.187% |
| GeoVax Labs, Inc. | -20.72 Million USD | 4309.96% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | -43780.08% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | 449026.491% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | -1651.503% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | 12400.282% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | 104446.411% |
| Vir Biotechnology, Inc. | 83.41 Million USD | -945.778% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -1193050.235% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | -1540.901% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 603.693% |
| Trevena, Inc. | 1.45 Million USD | -59854.364% |
| Surrozen, Inc. | -27.23 Million USD | 3303.584% |
| Tyra Biosciences, Inc. | -353 Thousand USD | 247220.68% |
| Cingulate Inc. | -582.91 Thousand USD | 149749.865% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | 2814087.097% |
| Unity Biotechnology, Inc. | -19.69 Million USD | 4528.326% |
| Tenax Therapeutics, Inc. | -7570.00 USD | 11523693.131% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | 99116.572% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | -28.152% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | 88393.117% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | 1548387.246% |
| Kronos Bio, Inc. | 1.37 Million USD | -63481.341% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | 1725.491% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | 298845.205% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | 178742.431% |
| ImmunityBio, Inc. | -17.89 Million USD | 4976.11% |
| Korro Bio, Inc. | -3.63 Million USD | 24131.295% |
| Kineta, Inc. | 5.43 Million USD | -15956.249% |
| BioVie Inc. | -229.37 Thousand USD | 380406.657% |
| Codexis, Inc. | 57.33 Million USD | -1421.499% |
| Celularity Inc. | 6.75 Million USD | -12813.93% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -21637.752% |
| Celcuity Inc. | -142.77 Thousand USD | 611099.356% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | -1724224.965% |
| Cibus, Inc. | 1.42 Million USD | -61245.71% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | 233344.92% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | 3906.17% |
| IN8bio, Inc. | -2.5 Million USD | 34979.488% |
| Kodiak Sciences Inc. | -25.94 Million USD | 3461.992% |
| Annexon, Inc. | -3.26 Million USD | 26801.439% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | 42777.886% |
| Assembly Biosciences, Inc. | -41.73 Million USD | 2190.078% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -136202.5% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | -12.051% |
| Eyenovia, Inc. | - USD | -Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | -404.372% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | 46012.421% |
| Arcellx, Inc. | 108.27 Million USD | -705.637% |
| Cardiff Oncology, Inc. | -32.36 Million USD | 2794.974% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | -1001.379% |
| Regulus Therapeutics Inc. | -21.15 Million USD | 4224.13% |
| Moolec Science SA | -143.3 Thousand USD | 608826.841% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | 2161.383% |
| Geron Corporation | -123.5 Million USD | 806.328% |
| LAVA Therapeutics N.V. | 3.28 Million USD | -26438.972% |
| Royalty Pharma plc | 1.79 Billion USD | 51.372% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 1344.594% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | 24151152.049% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | -376896.512% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 882.968% |
| Humacyte, Inc. | -76.55 Million USD | 1239.564% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | 92004.751% |
| 89bio, Inc. | -273 Thousand USD | 319636.996% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | 69498.25% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | -848 Thousand USD | 102969.811% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | 709316.26% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | -77856.747% |
| Notable Labs, Ltd. | 113 Thousand USD | -771878.761% |
| Liquidia Corporation | 14.6 Million USD | -5874.904% |
| Mustang Bio, Inc. | -2.22 Million USD | 39306.112% |
| Immunovant, Inc. | -231 Thousand USD | 377734.632% |
| Quantum-Si incorporated | 488 Thousand USD | -178657.377% |
| Arbutus Biopharma Corporation | -55.55 Million USD | 1670.107% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | 2907886.667% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -46749.409% |
| Acasti Pharma Inc. | -11 Thousand USD | 7930427.273% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | 426426.258% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 134625.502% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 620.76% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -76786.249% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | 229059.58% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | 44652.4% |
| PepGen Inc. | -1.18 Million USD | 73777.027% |
| Moleculin Biotech, Inc. | -127 Thousand USD | 686978.74% |
| United Therapeutics Corporation | 2.07 Billion USD | 57.858% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | 3909.827% |
| Solid Biosciences Inc. | -76.56 Million USD | 1239.37% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | 1056414.254% |
| Immuneering Corporation | -764.13 Thousand USD | 114259.484% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | -1316355.391% |
| Belite Bio, Inc | -399 Thousand USD | 218730.576% |
| XOMA Corporation | 3.86 Million USD | -22493.525% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | 4453.843% |
| Bionomics Limited | -434.44 Thousand USD | 200891.347% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 81323.091% |
| uniQure N.V. | 2.21 Million USD | -39283.115% |
| Cassava Sciences, Inc. | -89.42 Million USD | 1075.516% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 1047.481% |
| Forte Biosciences, Inc. | -9000.00 USD | 9692722.222% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | 104571.377% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | 199719.222% |
| Altimmune, Inc. | -65.37 Million USD | 1434.398% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | -140.957% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 81323.091% |
| Compugen Ltd. | 31.45 Million USD | -2673.282% |
| Peak Bio, Inc. | 367.76 Thousand USD | -237096.719% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | -3458.231% |
| Benitec Biopharma Inc. | 108 Thousand USD | -807618.519% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | 1118479.487% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | 72613.383% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | -1.82 Million USD | 47977.936% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | 733155.462% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | 72613.383% |
| Instil Bio, Inc. | -4.75 Million USD | 18441.8% |
| argenx SE | 1.1 Billion USD | 21.303% |
| Immunome, Inc. | -8.9 Million USD | 9893.825% |
| Compass Therapeutics, Inc. | -1.89 Million USD | 46255.344% |
| Verona Pharma plc | -679.62 Thousand USD | 128455.679% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | 498577.714% |
| Shattuck Labs, Inc. | -2.38 Million USD | 36675.933% |
| CervoMed Inc. | -1.29 Million USD | 67533.348% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | 36341.629% |
| Plus Therapeutics, Inc. | -4.77 Million USD | 18361.168% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | -35202.954% |
| Moolec Science SA | -143.3 Thousand USD | 608826.841% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | 213892.123% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | 32753.073% |
| AnaptysBio, Inc. | 14.78 Million USD | -5801.739% |
| Design Therapeutics, Inc. | -537 Thousand USD | 162546.182% |
| Leap Therapeutics, Inc. | -427 Thousand USD | 204394.145% |
| NeurAxis, Inc. | 2.15 Million USD | -40347.646% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | -40549.394% |
| Lumos Pharma, Inc. | 2 Million USD | -43364.674% |
| Achilles Therapeutics plc | -4.73 Million USD | 18537.683% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | 498577.714% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | 825589.472% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | -2655.434% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -101086.746% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | 84628.682% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | 2015.202% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | -2028588.372% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | 106223.601% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | 6629800.562% |
| Palisade Bio, Inc. | 246 Thousand USD | -354508.13% |
| Tourmaline Bio, Inc. | -33 Thousand USD | 2643542.424% |
| Beam Therapeutics Inc. | -59.67 Million USD | 1561.885% |
| Neurogene Inc. | -3.26 Million USD | 26842.367% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | -526.071% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | 23727.736% |
| Sesen Bio, Inc. | 40 Million USD | -2080.84% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | 293815.825% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | 21761.981% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | 9219.13% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | -6095.568% |
| Athira Pharma, Inc. | -969 Thousand USD | 90124.355% |
| Vaccinex, Inc. | -16 Million USD | 5550.737% |
| HCW Biologics Inc. | -574.82 Thousand USD | 151857.06% |
| XOMA Corporation | 3.86 Million USD | -22493.525% |
| Nektar Therapeutics | 53.47 Million USD | -1531.205% |
| Arvinas, Inc. | 71.8 Million USD | -1114.953% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Merus N.V. | -83.46 Million USD | 1145.202% |
| Omega Therapeutics, Inc. | -62.77 Million USD | 1489.623% |
| Quince Therapeutics, Inc. | -322 Thousand USD | 271011.801% |
| Rezolute, Inc. | -36 Thousand USD | 2423255.556% |
| Clene Inc. | 533 Thousand USD | -163565.291% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | 67939040.81% |
| BeyondSpring Inc. | 1.75 Million USD | -49719.303% |
| Synlogic, Inc. | -1.92 Million USD | 45439.709% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | 2357764.865% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | 13876.627% |
| Peak Bio, Inc. | 367.76 Thousand USD | -237096.719% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | 4700.2% |
| Krystal Biotech, Inc. | 47.6 Million USD | -1732.446% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | -518.279% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | -17259.92% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | 33791.086% |
| MannKind Corporation | 136.19 Million USD | -540.524% |
| Ikena Oncology, Inc. | -50.49 Million USD | 1827.672% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | -701.676% |
| Gossamer Bio, Inc. | -4.38 Million USD | 19993.637% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | 346265.079% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 17446820.0% |
| Legend Biotech Corporation | 140.92 Million USD | -518.99% |
| Mural Oncology plc | -2.56 Million USD | 34082.704% |
| Biora Therapeutics, Inc. | -551 Thousand USD | 158418.693% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | 872436.0% |
| Champions Oncology, Inc. | 20.75 Million USD | -4103.219% |
| REGENXBIO Inc. | 53.02 Million USD | -1545.017% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | 16384.182% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | 453556.01% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | 50465.82% |
| Vaxart, Inc. | -60.76 Million USD | 1535.637% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | 332064.381% |
| Cellectis S.A. | 18 Thousand USD | -4846211.111% |
| Longeveron Inc. | 221 Thousand USD | -394622.172% |
| Repare Therapeutics Inc. | -80.07 Million USD | 1189.467% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 20.188% |
| Inozyme Pharma, Inc. | -1.29 Million USD | 67513.91% |
| Revolution Medicines, Inc. | -399.66 Million USD | 318.267% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | 2492488.571% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | -1780177.551% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 89.865% |
| Denali Therapeutics Inc. | -93.34 Million USD | 1034.529% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 3482618.264% |
| Veru Inc. | 7.56 Million USD | -11429.795% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | 577805.96% |
| Cingulate Inc. | -582.91 Thousand USD | 149749.865% |
| Passage Bio, Inc. | -3.72 Million USD | 23543.59% |
| Context Therapeutics Inc. | -12.04 Thousand USD | 7243009.332% |
| Exicure, Inc. | -1.42 Million USD | 61402.6% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | 227863.969% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -32172.882% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | 170253.801% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | -1180.474% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | 583185.016% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | 1573.391% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | -223003.836% |
| OmniAb, Inc. | 14.66 Million USD | -5847.61% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | -4263.207% |
| Lipocine Inc. | -2.85 Million USD | 30699.498% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | 47432.393% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | 15390.727% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 58012.847% |
| G1 Therapeutics, Inc. | 75.31 Million USD | -1058.235% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | 1342155.385% |
| Sage Therapeutics, Inc. | 84.29 Million USD | -934.849% |
| Ocugen, Inc. | -33.53 Million USD | 2701.115% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | 27688.109% |
| Q32 Bio Inc. | 578 Thousand USD | -150823.183% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | 329283.396% |
| Alumis Inc. Common Stock | -1.28 Million USD | 68038.941% |
| Equillium, Inc. | 35.95 Million USD | -2325.986% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | 51203.456% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | -174130.595% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | 21101599.758% |
| Galera Therapeutics, Inc. | -259 Thousand USD | 336909.266% |
| Evelo Biosciences, Inc. | - USD | -Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | -206266.51% |
| Dominari Holdings Inc. | 2.03 Million USD | -42682.54% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | 475562.607% |
| vTv Therapeutics Inc. | -13.59 Million USD | 6516.594% |
| Bio-Techne Corporation | 773.07 Million USD | -12.84% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | -4936.873% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | -89.315% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | 74722.412% |
| Candel Therapeutics, Inc. | -23.98 Million USD | 3737.765% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | -7357.775% |
| Nkarta, Inc. | -5.86 Million USD | 14963.452% |
| BioCardia, Inc. | -7.24 Million USD | 12133.881% |
| Iterum Therapeutics plc | -1.75 Million USD | 49947.771% |